You are here:

MS in the media - 8 July 2016

Published on

25 June - 8 July 2016

These are links to news stories from the last fortnight that may be of interest to people in the UK. The link beneath each item will take you to the original story.

Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.

To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.

Overweight people more likely to develop MS

A Canadian study has found that a change in body mass index (BMI) from 'overweight' to 'obese' was associated with an increase in the risk of developing MS.

Source: Medical News Today

MS Trust link: Risk of developing MS

Gut bacteria differ in people with MS

Researchers found significant differences between the gut bacteria of people with MS and without MS, and also between treated and untreated people with MS. Further study is needed to determine whether alterations in the gut microbiome play a role in MS disease activity or are a consequence of it.

Source: National MS Society (USA)

Integrated care transforms lives of disabled people

Looks at how occupational therapists (OTs) are working with other services to help people with disabilities live independently at home.  Includes a case study is a woman with MS who had been sleeping in her living room.  The OT, working in a multidisciplinary team, was able to organise an new powered wheelchair and installation of a stair lift.

Source: Guardian

MS Trust link: Let's make MS care fair

Lifestyle based approach to MS

To mark the publication of the revised edition of George Jelinek's book Overcoming Multiple Ssclerosis, the Australian doctor talks about his mother's MS and how he came up with the lifestyle based approach that now keeps his own MS at bay.

Source: Daily Mail

MS Trust link: Lifestyle

Zinbryta (daclizumab) licensed

A new drug for relapsing remitting MS has been granted a licence by the EU. Zinbryta is a monthly injection that in trials reduced relapses by 45% compared to Avonex. It also slowed the build up of disability and led to fewer new lesions seen on MRIs.

Source: Biogen press release

MS Trust link: Zinbryta (daclizumab)

Effect of MS on carers

A Canadian survey found that looking after someone with MS affected the mental health scores of about a third of respondents, with the most common effects being fatigue (42%), anger or hostility (20%) and depression or dejection (14%).  Empathy for the person for whom they cared was unaffected

Source: MS News Today

MS Trust link: Carers

Cause of depression as MS symptom

As well as mood being affected by living with a long-term condition, UK research suggests that inflammation affecting an area of the brain called the hippocampus may be the cause of depression being a direct symptom of MS.

Source: Science Daily

MS Trust link: Depression